FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction
FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction The U.S. Food and Drug Administration (FDA) announced on April 23, 2020 that it has sent warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). […]